CRISPR Therapeutics AG — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| KASINGER JAMES R. | General Counsel and Secretary | Tax Withholding | 1,950 | $48.26 | $94,107 | 52,066 | Feb 18, 2023 |
| Kulkarni Samarth | Chief Executive Officer | Option Exercise | 25,000 | $19.12 | $478,000 | 394,111 | Jan 27, 2023 |
| Kulkarni Samarth | Chief Executive Officer | Sale | 4,634 | $41.45 | $192,079 | 369,111 | Dec 28, 2022 |
| Kulkarni Samarth | Chief Executive Officer | Option Exercise | 58,233 | $1.81 | $105,402 | 369,111 | Dec 6, 2022 |
| KASINGER JAMES R. | General Counsel and Secretary | Option Exercise | 6,667 | — | — | 53,425 | Dec 5, 2022 |
| Kulkarni Samarth | Chief Executive Officer | Tax Withholding | 19,401 | $52.26 | $1,013,896 | 310,878 | Dec 3, 2022 |
| Kulkarni Samarth | Chief Executive Officer | Sale | 5,572 | $54.85 | $305,624 | 292,589 | Nov 28, 2022 |
| Kulkarni Samarth | Chief Executive Officer | Sale | 7,188 | $55.69 | $400,300 | 290,279 | Oct 26, 2022 |
| Smith Brendan | Chief Financial Officer | Option Exercise | 3,750 | — | — | 3,750 | Oct 17, 2022 |
| Kulkarni Samarth | Chief Executive Officer | Sale | 23,200 | $64.58 | $1,498,256 | 292,079 | Sep 28, 2022 |
| Kulkarni Samarth | Chief Executive Officer | Sale | 4,073 | $66.14 | $269,388 | 311,206 | Aug 29, 2022 |
| Kulkarni Samarth | Chief Executive Officer | Option Exercise | 8,333 | $12.57 | $104,746 | 298,612 | Jul 27, 2022 |
| Kulkarni Samarth | Chief Executive Officer | Sale | 4,740 | $62.32 | $295,397 | 290,279 | Jun 29, 2022 |
| KASINGER JAMES R. | General Counsel and Secretary | Option Exercise | 2,834 | — | — | 46,539 | Mar 14, 2022 |
| Kulkarni Samarth | Chief Executive Officer | Tax Withholding | 5,487 | $62.56 | $343,267 | 285,432 | Mar 11, 2022 |
| Klein Lawrence Otto | CBO & COO | Option Exercise | 4,584 | — | — | 26,909 | Mar 11, 2022 |
| Kulkarni Samarth | Chief Executive Officer | Option Exercise | 17,750 | $1.81 | $32,128 | 279,085 | Dec 20, 2021 |
| Kulkarni Samarth | Chief Executive Officer | Option Exercise | 80,000 | — | — | 299,153 | Dec 6, 2021 |
| Klein Lawrence Otto | CBO & COO | Tax Withholding | 11,185 | $69.17 | $773,666 | 22,325 | Dec 3, 2021 |
| Ho Tony W | Executive VP, Head of R&D | Tax Withholding | 12,607 | $69.17 | $872,026 | 52,364 | Dec 3, 2021 |
| KASINGER JAMES R. | General Counsel and Secretary | Tax Withholding | 6,303 | $69.17 | $435,979 | 43,542 | Dec 3, 2021 |
| KASINGER JAMES R. | General Counsel and Secretary | Option Exercise | 7,342 | $13.62 | $99,998 | 36,512 | Dec 2, 2021 |
| Kulkarni Samarth | Chief Executive Officer | Tax Withholding | 779 | $75.10 | $58,503 | 219,153 | Dec 1, 2021 |
| Kulkarni Samarth | Chief Executive Officer | Option Exercise | 33,000 | $1.81 | $59,730 | 219,932 | Oct 15, 2021 |
| KASINGER JAMES R. | General Counsel and Secretary | Option Exercise | 10,000 | — | — | 33,911 | Sep 13, 2021 |
| Klein Lawrence Otto | CBO & COO | Option Exercise | 10,000 | — | — | 11,050 | Sep 13, 2021 |
| Kulkarni Samarth | Chief Executive Officer | Tax Withholding | 787 | $124.83 | $98,241 | 186,932 | Sep 1, 2021 |
| TOMSICEK MICHAEL JOHN | Chief Financial Officer | Sale | 5,989 | $139.46 | $835,226 | 1,891 | Aug 6, 2021 |
| Kulkarni Samarth | Chief Executive Officer | Sale | 4,700 | $127.82 | $600,754 | 210,519 | Aug 5, 2021 |
| Bolzon Bradley J PhD | — | Sale | 1,324 | $127.36 | $168,625 | 149,531 | Jul 19, 2021 |
| Novak Rodger | President | Sale | 25,000 | $165.00 | $4,125,000 | 573,007 | Jun 30, 2021 |
| Bolzon Bradley J PhD | — | Other | 158,522 | — | — | 158,522 | Jun 28, 2021 |
| Bolzon Bradley J PhD | — | Sale | 4,519 | $153.54 | $693,847 | 3,098 | Jun 28, 2021 |
| Novak Rodger | President | Sale | 25,000 | $156.55 | $3,913,750 | 598,007 | Jun 28, 2021 |
| Novak Rodger | President | Sale | 1,171 | $125.58 | $147,054 | 646,836 | Jun 21, 2021 |
| Kulkarni Samarth | Chief Executive Officer | Sale | 3,488 | $127.51 | $444,755 | 187,719 | Jun 15, 2021 |
| Bolzon Bradley J PhD | — | Sale | 800 | $127.88 | $102,304 | 22,230 | Jun 11, 2021 |
| Kulkarni Samarth | Chief Executive Officer | Tax Withholding | 779 | $115.80 | $90,208 | 187,719 | Jun 1, 2021 |
| Klein Lawrence Otto | CBO & COO | Option Exercise | 12,000 | $17.66 | $211,920 | 101,050 | Mar 23, 2021 |
| Bolzon Bradley J PhD | — | Sale | 300 | $134.93 | $40,479 | 30,375 | Mar 22, 2021 |
| TOMSICEK MICHAEL JOHN | Chief Financial Officer | Option Exercise | 2,833 | — | — | 3,243 | Mar 10, 2021 |
| Kulkarni Samarth | Chief Executive Officer | Tax Withholding | 5,526 | $124.15 | $686,053 | 188,498 | Mar 10, 2021 |
| Klein Lawrence Otto | CBO & COO | Option Exercise | 4,583 | — | — | 15,191 | Mar 10, 2021 |
| KASINGER JAMES R. | General Counsel and Secretary | Tax Withholding | 1,353 | $124.15 | $167,975 | 23,911 | Mar 10, 2021 |
| Ho Tony W | Executive VP, Head of R&D | Tax Withholding | 2,141 | $124.15 | $265,805 | 38,304 | Mar 10, 2021 |
| Ho Tony W | Executive VP, Head of R&D | Tax Withholding | 1,585 | $114.65 | $181,720 | 35,862 | Mar 5, 2021 |
| Bolzon Bradley J PhD | — | Other | 18,574 | — | — | 44,295 | Mar 1, 2021 |
| Kulkarni Samarth | Chief Executive Officer | Tax Withholding | 798 | $130.25 | $103,940 | 182,191 | Mar 1, 2021 |
| Bolzon Bradley J PhD | — | Other | 27,861 | — | — | 62,869 | Feb 19, 2021 |
| KASINGER JAMES R. | General Counsel and Secretary | Sale | 8,997 | $205.60 | $1,849,783 | 26,331 | Jan 19, 2021 |